open access

Vol 67, No 8 (2009)
Other
Published online: 2009-09-09
Submitted: 2012-12-28
Get Citation

Cardiac surgery and cardiology
POL-TAVI FIRST – Polish report on transcatheter aortic valve implantation (TAVI) of Edwards- -Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities

Marian Zembala, Krzysztof Wilczek, Roman Przybylski, Piotr Chodór, Paweł Nadziakiewicz, Marcin Krasoń, Jerzy Sadowski, Dariusz Dudek, Boguslaw Kapelak, Danuta Sorysz, Adam Witkowski, Marcin Demkow, Zbigniew Chmielak, Krzysztof Kuśmierski, Zbigniew Juraszyński, Andrzej Bochenek, Marek Cisowski, Maria Trusz-Gluza, Paweł Buszman, Stanisław Woś, Zbigniew Kalarus, Lech Poloński, Mariusz Gąsior, Grzegorz Opolski, Witold Rużyłło
Kardiol Pol 2009;67(8):936-940.

open access

Vol 67, No 8 (2009)
Other
Published online: 2009-09-09
Submitted: 2012-12-28

Abstract

Patients with severe symptomatic aortic stenosis, who from November 2008 to March 2009 were treated with Edwards-Sapien transcatheter aortic valve implantation (TAVI) within the POL-TAVI First Polish Registry, were included in the analysis. Nineteen patients aged 78±4,8 years with high operation risk and Logistic EuroSCORE 25 ± 7.6% were reported (74% were females). In 15 (79%) patients the valve was implanted transapically (TA), in the other four (21%) – via the femoral arterial access (TF). The valve was successfully implanted in 16 (84%) patients, in one patient aortic valvuloplasty alone was performed. During in-hospital period two patients died (one during periprocedural period and another one – two months after the implantation). During the mean follow-up of 5 ± 1.5 months (except for one patient who is still in hospital) all patients are in NYHA class I or II. Results of the initial series of 19 TAVI patients in Poland are satisfactory, and the trial will be continued with careful medical and economical analysis.

Abstract

Patients with severe symptomatic aortic stenosis, who from November 2008 to March 2009 were treated with Edwards-Sapien transcatheter aortic valve implantation (TAVI) within the POL-TAVI First Polish Registry, were included in the analysis. Nineteen patients aged 78±4,8 years with high operation risk and Logistic EuroSCORE 25 ± 7.6% were reported (74% were females). In 15 (79%) patients the valve was implanted transapically (TA), in the other four (21%) – via the femoral arterial access (TF). The valve was successfully implanted in 16 (84%) patients, in one patient aortic valvuloplasty alone was performed. During in-hospital period two patients died (one during periprocedural period and another one – two months after the implantation). During the mean follow-up of 5 ± 1.5 months (except for one patient who is still in hospital) all patients are in NYHA class I or II. Results of the initial series of 19 TAVI patients in Poland are satisfactory, and the trial will be continued with careful medical and economical analysis.
Get Citation

Keywords

severe aortic stenosis; transcatheter aortic valve implantation; Edwards-Sapien valve

About this article
Title

Cardiac surgery and cardiology
POL-TAVI FIRST – Polish report on transcatheter aortic valve implantation (TAVI) of Edwards- -Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 67, No 8 (2009)

Pages

936-940

Published online

2009-09-09

Bibliographic record

Kardiol Pol 2009;67(8):936-940.

Keywords

severe aortic stenosis
transcatheter aortic valve implantation
Edwards-Sapien valve

Authors

Marian Zembala
Krzysztof Wilczek
Roman Przybylski
Piotr Chodór
Paweł Nadziakiewicz
Marcin Krasoń
Jerzy Sadowski
Dariusz Dudek
Boguslaw Kapelak
Danuta Sorysz
Adam Witkowski
Marcin Demkow
Zbigniew Chmielak
Krzysztof Kuśmierski
Zbigniew Juraszyński
Andrzej Bochenek
Marek Cisowski
Maria Trusz-Gluza
Paweł Buszman
Stanisław Woś
Zbigniew Kalarus
Lech Poloński
Mariusz Gąsior
Grzegorz Opolski
Witold Rużyłło

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl